雷宁-血管激素系统:自身免疫性皮肤病背后的挑战
Minela Aida Maranduca1,2, Mihai Andrei Cosovanu1, Andreea Clim1
1Discipline of Physiology, Department of Morpho-Functional Sciences II, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Diagnostics (Basel, Switzerland)
|November 24, 2023
概括
氨酸-血管素系统 (RAS) 在自身免疫性皮肤疾病中起着关键作用. 调节RAS组件为牛皮和狼等疾病提供了潜在的新疗法.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 心血管研究研究心血管研究
- 分子生物学分子生物学
背景情况:
- 自免疫性皮肤病 (AIDD) 涉及免疫系统对皮肤的攻击.
- 以血压调节而闻名的氨酸- ангиотензин系统 (RAS) 越来越多地与炎症和免疫反应有关.
- 异常RAS活动可能有助于AIDD的发展和进展.
研究的目的:
- 审查氨酸- ангиотензин系统 (RAS) 在自身免疫性皮肤病 (AIDD) 中的作用.
- 探索潜在的治疗策略,以RAS作为AIDD治疗的目标.
主要方法:
- 对RAS和AIDD现有的文献进行系统审查.
- 对皮肤和免疫细胞中RAS成分的实验研究的分析.
- 检查其他RAS通路及其参与皮肤平衡的研究.
主要成果:
- RAS的主要作用因子 ангиотензин II 对AT1R和AT2R起作用,AT1R的激活促进了皮肤的炎症和组织重塑.
- 实验研究证实了AT1R在皮肤细胞和免疫细胞中的存在,这表明它在AIDD病变发生过程中的作用.
- 涉及ACE2,Ang受体和Ang-(1-7) 的替代RAS通路与皮肤微环境中的免疫调节和组织平衡有关.
结论:
- 氨酸- ангиотензин系统 (RAS) 复杂地参与了自身免疫性皮肤疾病的病理生理学.
- 向RAS成分,包括使用血管激素受体抑制剂 (ARB) 和ACE抑制剂 (ACEI),为AIDD提供了有前途的治疗途径.
- 进一步的研究至关重要,以阐明RAS介导的免疫失调在AIDD的精确机制,并优化向治疗.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
640
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
640
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
656
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
656
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Autoimmune Disorders
449
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
449
Antihypertensive Drugs: Angiotensin II Receptor Blockers
748
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
748


